These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 9203092
1. Inositol treatment of autism. Levine J, Aviram A, Holan A, Ring A, Barak Y, Belmaker RH. J Neural Transm (Vienna); 1997; 104(2-3):307-10. PubMed ID: 9203092 [Abstract] [Full Text] [Related]
2. Controlled trials of inositol in psychiatry. Levine J. Eur Neuropsychopharmacol; 1997 May; 7(2):147-55. PubMed ID: 9169302 [Abstract] [Full Text] [Related]
3. Inositol treatment of obsessive-compulsive disorder. Fux M, Levine J, Aviv A, Belmaker RH. Am J Psychiatry; 1996 Sep; 153(9):1219-21. PubMed ID: 8780431 [Abstract] [Full Text] [Related]
4. Differential response of seven subjects with autistic disorder to clomipramine and desipramine. Gordon CT, Rapoport JL, Hamburger SD, State RC, Mannheim GB. Am J Psychiatry; 1992 Mar; 149(3):363-6. PubMed ID: 1536276 [Abstract] [Full Text] [Related]
8. Tetrahydrobiopterin in the treatment of children with autistic disorder: a double-blind placebo-controlled crossover study. Danfors T, von Knorring AL, Hartvig P, Langstrom B, Moulder R, Stromberg B, Torstenson R, Wester U, Watanabe Y, Eeg-Olofsson O. J Clin Psychopharmacol; 2005 Oct; 25(5):485-9. PubMed ID: 16160627 [Abstract] [Full Text] [Related]
11. Effect of inositol on bulimia nervosa and binge eating. Gelber D, Levine J, Belmaker RH. Int J Eat Disord; 2001 Apr; 29(3):345-8. PubMed ID: 11262515 [Abstract] [Full Text] [Related]
12. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. Anderson LT, Campbell M, Grega DM, Perry R, Small AM, Green WH. Am J Psychiatry; 1984 Oct; 141(10):1195-202. PubMed ID: 6385731 [Abstract] [Full Text] [Related]
13. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E. Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983 [Abstract] [Full Text] [Related]
14. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B. Am J Psychiatry; 2005 Jun; 162(6):1142-8. PubMed ID: 15930063 [Abstract] [Full Text] [Related]
15. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder. Rezaei V, Mohammadi MR, Ghanizadeh A, Sahraian A, Tabrizi M, Rezazadeh SA, Akhondzadeh S. Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct 01; 34(7):1269-72. PubMed ID: 20637249 [Abstract] [Full Text] [Related]
18. High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study. Findling RL, Maxwell K, Scotese-Wojtila L, Huang J, Yamashita T, Wiznitzer M. J Autism Dev Disord; 1997 Aug 01; 27(4):467-78. PubMed ID: 9261669 [Abstract] [Full Text] [Related]